PROSTAGLANDINS IN CONGENITAL HEART DISEASE.
作者信息
Sharma M, Sasikumar M, Karloopia S D, Shahi B N
机构信息
Classified Specialist (Pediatric Cardiology), Army Hospital (R & R), Delhi.
Senior Advisor (Cardiology), Army Hospital (R & R), Delhi.
出版信息
Med J Armed Forces India. 2001 Apr;57(2):134-8. doi: 10.1016/S0377-1237(01)80134-9. Epub 2011 Jul 21.
Abstract
摘要
相似文献
1
PROSTAGLANDINS IN CONGENITAL HEART DISEASE.
Med J Armed Forces India. 2001 Apr;57(2):134-8. doi: 10.1016/S0377-1237(01)80134-9. Epub 2011 Jul 21.
2
[Use of prostaglandins in neonatal cardiology].
Med Arh. 2000;54(5-6):279-82.
3
Role of prostaglandins in congenital heart disease.
Indian Pediatr. 1993 Mar;30(3):387-91.
4
Use of prostaglandins in duct-dependent congenital heart conditions.
Arch Dis Child Educ Pract Ed. 2018 Jun;103(3):137-140. doi: 10.1136/archdischild-2017-313654. Epub 2017 Nov 21.
5
[Prostaglandins in congenital heart defects of the pale type in young children].
Pediatriia. 1987(6):108-9.
6
Endogenous dilator prostaglandins in congenital heart disease.
Pediatr Cardiol. 1987;8(3):155-9. doi: 10.1007/BF02263445.
7
Introduction to cardiovascular research on prostaglandins.
Adv Prostaglandin Thromboxane Res. 1976;1:395-401.
8
Prostaglandins and the management of congenital heart disease.
Am Fam Physician. 1982 Dec;26(6):127-32.
9
Pulmonary hypertension in congenital heart disease.
Nurs Stand. 2005;19(50):41-9. doi: 10.7748/ns2005.08.19.50.41.c3940.
10
Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease.
N Engl J Med. 1981 Mar 19;304(12):685-91. doi: 10.1056/NEJM198103193041201.
本文引用的文献
1
Prostaglandin E1 in infants with congenital heart disease: Indian experience.
Indian Pediatr. 1998 Nov;35(11):1063-9.
2
Acute gastric outlet obstruction following the administration of prostaglandin: an additional case.
Pediatr Radiol. 1997 Jan;27(1):57-9. doi: 10.1007/s002470050064.
3
Idiopathic arterial calcification of infancy: effectiveness of prostaglandin infusion for treatment of secondary hypertension refractory to conventional therapy: case report.
Pediatr Cardiol. 1997 Jan-Feb;18(1):67-71. doi: 10.1007/s002469900114.
4
Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
Eur J Pediatr. 1996 Mar;155(3):173-4. doi: 10.1007/BF01953932.
5
Bone and tissue changes following prostaglandin therapy in neonates.
Ann Pharmacother. 1996 Mar;30(3):269-74, 277. doi: 10.1177/106002809603000311.
6
Aneurysmal change of the ductus arteriosus after prostaglandin E1 administration for pulmonary atresia: demonstration with magnetic resonance imaging.
Pediatr Cardiol. 1994 Jan-Feb;15(1):30-2. doi: 10.1007/BF00797003.
7
Cortical hyperostosis: a complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation.
Pediatrics. 1994 Mar;93(3):417-20.
8
Prostaglandin-induced foveolar hyperplasia simulating pyloric stenosis in an infant with cyanotic heart disease.
Pediatr Radiol. 1994;24(1):45-6. doi: 10.1007/BF02017660.
9
Prostaglandin-induced neonatal periostitis.
J Pediatr Orthop. 1994 Nov-Dec;14(6):809-13. doi: 10.1097/01241398-199414060-00023.
10
Oral prostaglandin E2 in ductus-dependent pulmonary circulation.
Circulation. 1981 Mar;63(3):682-8. doi: 10.1161/01.cir.63.3.682.
Zotero 插件